|
Jul 25
|
Why Elanco (ELAN) Stock Is Trading Up Today
|
|
Jul 24
|
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
|
|
Jul 24
|
ELAN vs. USPH: Which Stock Is the Better Value Option?
|
|
Jul 22
|
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
|
|
Jul 21
|
Veterinary Dermatology - Company Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion
|
|
Jul 17
|
Starbucks downgraded, Oracle initiated: Wall Street's top analyst calls
|
|
Jul 15
|
Are Options Traders Betting on a Big Move in ELAN Stock?
|
|
Jul 10
|
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement
|
|
Jul 9
|
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection
|
|
Jun 30
|
5 Revealing Analyst Questions From Elanco’s Q1 Earnings Call
|
|
Jun 26
|
Elanco Releases 2024 Impact Report and Introduces New Framework
|
|
Jun 26
|
General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls
|
|
Jun 20
|
Shareholders in Elanco Animal Health (NYSE:ELAN) have lost 37%, as stock drops 3.5% this past week
|
|
Jun 12
|
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)
|
|
Jun 11
|
ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty
|
|
Jun 10
|
What Makes Elanco Animal Health (ELAN) a New Buy Stock
|
|
Jun 10
|
ELAN vs. USPH: Which Stock Should Value Investors Buy Now?
|
|
Jun 10
|
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?
|
|
Jun 9
|
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?
|
|
May 28
|
How Elanco Plans on Winning in the Pet Wellness Boom
|